0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autologous Cell Therapy Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-8V15270
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autologous Cell Therapy Market Insights Forecast to 2029
BUY CHAPTERS

Global Autologous Cell Therapy Market Insights, Forecast to 2030

Code: QYRE-Auto-8V15270
Report
December 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Autologous Cell Therapy Market Size

The global Autologous Cell Therapy market is projected to grow from US$ 8388.9 million in 2024 to US$ 16920 million by 2030, at a Compound Annual Growth Rate (CAGR) of 12.4% during the forecast period.

Autologous Cell Therapy Market

Autologous Cell Therapy Market

Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.
Market Analysis and Insights: Global Autologous Cell Therapy Market
The US & Canada market for Autologous Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Autologous Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Autologous Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Autologous Cell Therapy include BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Vericel Corporation and Regeneus, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Autologous Cell Therapy is widely used in various fields, such as Neurology, Orthopedics, Cancer and Wound Healing, etc. Neurology provides greatest supports to the Autologous Cell Therapy industry development. In 2023, global % revenue of Autologous Cell Therapy went into Neurology filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Autologous Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Autologous Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Autologous Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Autologous Cell Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Autologous Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Autologous Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Autologous Cell Therapy Market Report

Report Metric Details
Report Name Autologous Cell Therapy Market
Accounted market size in 2024 US$ 8388.9 million
Forecasted market size in 2030 US$ 16920 million
CAGR 12.4
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Neurology
  • Orthopedics
  • Cancer
  • Wound Healing
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Vericel Corporation, Regeneus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Autologous Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Autologous Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autologous Cell Therapy revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Autologous Cell Therapy Market growing?

Ans: The Autologous Cell Therapy Market witnessing a CAGR of 12.4 during the forecast period 2025-2030.

What is the Autologous Cell Therapy Market size in 2030?

Ans: The Autologous Cell Therapy Market size in 2030 will be US$ 16920 million.

Who are the main players in the Autologous Cell Therapy Market report?

Ans: The main players in the Autologous Cell Therapy Market are BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Vericel Corporation, Regeneus

What are the Application segmentation covered in the Autologous Cell Therapy Market report?

Ans: The Applications covered in the Autologous Cell Therapy Market report are Neurology, Orthopedics, Cancer, Wound Healing, Others

What are the Type segmentation covered in the Autologous Cell Therapy Market report?

Ans: The Types covered in the Autologous Cell Therapy Market report are Bone Marrow, Epidermis

Recommended Reports

Cell Therapy Markets

Regenerative Medicine

Cell and Gene Tools

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Bone Marrow
1.2.3 Epidermis
1.3 Market by Application
1.3.1 Global Autologous Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Neurology
1.3.3 Orthopedics
1.3.4 Cancer
1.3.5 Wound Healing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous Cell Therapy Market Perspective (2019-2030)
2.2 Global Autologous Cell Therapy Growth Trends by Region
2.2.1 Autologous Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autologous Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Autologous Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Autologous Cell Therapy Market Dynamics
2.3.1 Autologous Cell Therapy Industry Trends
2.3.2 Autologous Cell Therapy Market Drivers
2.3.3 Autologous Cell Therapy Market Challenges
2.3.4 Autologous Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Autologous Cell Therapy by Players
3.1.1 Global Autologous Cell Therapy Revenue by Players (2019-2024)
3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Autologous Cell Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Autologous Cell Therapy Market Concentration Ratio
3.4.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2023
3.5 Global Key Players of Autologous Cell Therapy Head office and Area Served
3.6 Global Key Players of Autologous Cell Therapy, Product and Application
3.7 Global Key Players of Autologous Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Cell Therapy Breakdown Data by Type
4.1 Global Autologous Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Autologous Cell Therapy Breakdown Data by Application
5.1 Global Autologous Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autologous Cell Therapy Market Size (2019-2030)
6.2 North America Autologous Cell Therapy Market Size by Type
6.2.1 North America Autologous Cell Therapy Market Size by Type (2019-2024)
6.2.2 North America Autologous Cell Therapy Market Size by Type (2025-2030)
6.2.3 North America Autologous Cell Therapy Market Share by Type (2019-2030)
6.3 North America Autologous Cell Therapy Market Size by Application
6.3.1 North America Autologous Cell Therapy Market Size by Application (2019-2024)
6.3.2 North America Autologous Cell Therapy Market Size by Application (2025-2030)
6.3.3 North America Autologous Cell Therapy Market Share by Application (2019-2030)
6.4 North America Autologous Cell Therapy Market Size by Country
6.4.1 North America Autologous Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Autologous Cell Therapy Market Size by Country (2019-2024)
6.4.3 North America Autologous Cell Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Autologous Cell Therapy Market Size (2019-2030)
7.2 Europe Autologous Cell Therapy Market Size by Type
7.2.1 Europe Autologous Cell Therapy Market Size by Type (2019-2024)
7.2.2 Europe Autologous Cell Therapy Market Size by Type (2025-2030)
7.2.3 Europe Autologous Cell Therapy Market Share by Type (2019-2030)
7.3 Europe Autologous Cell Therapy Market Size by Application
7.3.1 Europe Autologous Cell Therapy Market Size by Application (2019-2024)
7.3.2 Europe Autologous Cell Therapy Market Size by Application (2025-2030)
7.3.3 Europe Autologous Cell Therapy Market Share by Application (2019-2030)
7.4 Europe Autologous Cell Therapy Market Size by Country
7.4.1 Europe Autologous Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Autologous Cell Therapy Market Size by Country (2019-2024)
7.4.3 Europe Autologous Cell Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Autologous Cell Therapy Market Size (2019-2030)
8.2 China Autologous Cell Therapy Market Size by Type
8.2.1 China Autologous Cell Therapy Market Size by Type (2019-2024)
8.2.2 China Autologous Cell Therapy Market Size by Type (2025-2030)
8.2.3 China Autologous Cell Therapy Market Share by Type (2019-2030)
8.3 China Autologous Cell Therapy Market Size by Application
8.3.1 China Autologous Cell Therapy Market Size by Application (2019-2024)
8.3.2 China Autologous Cell Therapy Market Size by Application (2025-2030)
8.3.3 China Autologous Cell Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Autologous Cell Therapy Market Size (2019-2030)
9.2 Asia Autologous Cell Therapy Market Size by Type
9.2.1 Asia Autologous Cell Therapy Market Size by Type (2019-2024)
9.2.2 Asia Autologous Cell Therapy Market Size by Type (2025-2030)
9.2.3 Asia Autologous Cell Therapy Market Share by Type (2019-2030)
9.3 Asia Autologous Cell Therapy Market Size by Application
9.3.1 Asia Autologous Cell Therapy Market Size by Application (2019-2024)
9.3.2 Asia Autologous Cell Therapy Market Size by Application (2025-2030)
9.3.3 Asia Autologous Cell Therapy Market Share by Application (2019-2030)
9.4 Asia Autologous Cell Therapy Market Size by Region
9.4.1 Asia Autologous Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Autologous Cell Therapy Market Size by Region (2019-2024)
9.4.3 Asia Autologous Cell Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Autologous Cell Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Autologous Cell Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BioTime
11.1.1 BioTime Company Details
11.1.2 BioTime Business Overview
11.1.3 BioTime Autologous Cell Therapy Introduction
11.1.4 BioTime Revenue in Autologous Cell Therapy Business (2019-2024)
11.1.5 BioTime Recent Developments
11.2 Pharmicell
11.2.1 Pharmicell Company Details
11.2.2 Pharmicell Business Overview
11.2.3 Pharmicell Autologous Cell Therapy Introduction
11.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2019-2024)
11.2.5 Pharmicell Recent Developments
11.3 BrainStorm Cell Therapeutics
11.3.1 BrainStorm Cell Therapeutics Company Details
11.3.2 BrainStorm Cell Therapeutics Business Overview
11.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction
11.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2019-2024)
11.3.5 BrainStorm Cell Therapeutics Recent Developments
11.4 Opexa Therapeutics
11.4.1 Opexa Therapeutics Company Details
11.4.2 Opexa Therapeutics Business Overview
11.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction
11.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2019-2024)
11.4.5 Opexa Therapeutics Recent Developments
11.5 Vericel Corporation
11.5.1 Vericel Corporation Company Details
11.5.2 Vericel Corporation Business Overview
11.5.3 Vericel Corporation Autologous Cell Therapy Introduction
11.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2019-2024)
11.5.5 Vericel Corporation Recent Developments
11.6 Regeneus
11.6.1 Regeneus Company Details
11.6.2 Regeneus Business Overview
11.6.3 Regeneus Autologous Cell Therapy Introduction
11.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2019-2024)
11.6.5 Regeneus Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Autologous Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Bone Marrow
    Table 3. Key Players of Epidermis
    Table 4. Global Autologous Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Autologous Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Autologous Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Autologous Cell Therapy Market Share by Region (2019-2024)
    Table 8. Global Autologous Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Autologous Cell Therapy Market Share by Region (2025-2030)
    Table 10. Autologous Cell Therapy Market Trends
    Table 11. Autologous Cell Therapy Market Drivers
    Table 12. Autologous Cell Therapy Market Challenges
    Table 13. Autologous Cell Therapy Market Restraints
    Table 14. Global Autologous Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Autologous Cell Therapy Revenue Share by Players (2019-2024)
    Table 16. Global Top Autologous Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy as of 2023)
    Table 17. Global Autologous Cell Therapy Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Autologous Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Autologous Cell Therapy, Headquarters and Area Served
    Table 20. Global Key Players of Autologous Cell Therapy, Product and Application
    Table 21. Global Key Players of Autologous Cell Therapy, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Autologous Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Autologous Cell Therapy Revenue Market Share by Type (2019-2024)
    Table 25. Global Autologous Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Autologous Cell Therapy Revenue Market Share by Type (2025-2030)
    Table 27. Global Autologous Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Autologous Cell Therapy Revenue Share by Application (2019-2024)
    Table 29. Global Autologous Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Autologous Cell Therapy Revenue Share by Application (2025-2030)
    Table 31. North America Autologous Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Autologous Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Autologous Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Autologous Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Autologous Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Autologous Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Autologous Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Autologous Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Autologous Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Autologous Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Autologous Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Autologous Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Autologous Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Autologous Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Autologous Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Autologous Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Autologous Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Autologous Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Autologous Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Autologous Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Autologous Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Autologous Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Autologous Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Autologous Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Autologous Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Autologous Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Autologous Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 63. BioTime Company Details
    Table 64. BioTime Business Overview
    Table 65. BioTime Autologous Cell Therapy Product
    Table 66. BioTime Revenue in Autologous Cell Therapy Business (2019-2024) & (US$ Million)
    Table 67. BioTime Recent Developments
    Table 68. Pharmicell Company Details
    Table 69. Pharmicell Business Overview
    Table 70. Pharmicell Autologous Cell Therapy Product
    Table 71. Pharmicell Revenue in Autologous Cell Therapy Business (2019-2024) & (US$ Million)
    Table 72. Pharmicell Recent Developments
    Table 73. BrainStorm Cell Therapeutics Company Details
    Table 74. BrainStorm Cell Therapeutics Business Overview
    Table 75. BrainStorm Cell Therapeutics Autologous Cell Therapy Product
    Table 76. BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2019-2024) & (US$ Million)
    Table 77. BrainStorm Cell Therapeutics Recent Developments
    Table 78. Opexa Therapeutics Company Details
    Table 79. Opexa Therapeutics Business Overview
    Table 80. Opexa Therapeutics Autologous Cell Therapy Product
    Table 81. Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2019-2024) & (US$ Million)
    Table 82. Opexa Therapeutics Recent Developments
    Table 83. Vericel Corporation Company Details
    Table 84. Vericel Corporation Business Overview
    Table 85. Vericel Corporation Autologous Cell Therapy Product
    Table 86. Vericel Corporation Revenue in Autologous Cell Therapy Business (2019-2024) & (US$ Million)
    Table 87. Vericel Corporation Recent Developments
    Table 88. Regeneus Company Details
    Table 89. Regeneus Business Overview
    Table 90. Regeneus Autologous Cell Therapy Product
    Table 91. Regeneus Revenue in Autologous Cell Therapy Business (2019-2024) & (US$ Million)
    Table 92. Regeneus Recent Developments
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Autologous Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Autologous Cell Therapy Market Share by Type: 2023 VS 2030
    Figure 3. Bone Marrow Features
    Figure 4. Epidermis Features
    Figure 5. Global Autologous Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Autologous Cell Therapy Market Share by Application: 2023 VS 2030
    Figure 7. Neurology Case Studies
    Figure 8. Orthopedics Case Studies
    Figure 9. Cancer Case Studies
    Figure 10. Wound Healing Case Studies
    Figure 11. Others Case Studies
    Figure 12. Autologous Cell Therapy Report Years Considered
    Figure 13. Global Autologous Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Autologous Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Autologous Cell Therapy Market Share by Region: 2023 VS 2030
    Figure 16. Global Autologous Cell Therapy Market Share by Players in 2023
    Figure 17. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2023
    Figure 19. North America Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Autologous Cell Therapy Market Share by Type (2019-2030)
    Figure 21. North America Autologous Cell Therapy Market Share by Application (2019-2030)
    Figure 22. North America Autologous Cell Therapy Market Share by Country (2019-2030)
    Figure 23. United States Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Autologous Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Autologous Cell Therapy Market Share by Type (2019-2030)
    Figure 27. Europe Autologous Cell Therapy Market Share by Application (2019-2030)
    Figure 28. Europe Autologous Cell Therapy Market Share by Country (2019-2030)
    Figure 29. Germany Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Autologous Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Autologous Cell Therapy Market Share by Type (2019-2030)
    Figure 37. China Autologous Cell Therapy Market Share by Application (2019-2030)
    Figure 38. Asia Autologous Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Autologous Cell Therapy Market Share by Type (2019-2030)
    Figure 40. Asia Autologous Cell Therapy Market Share by Application (2019-2030)
    Figure 41. Asia Autologous Cell Therapy Market Share by Region (2019-2030)
    Figure 42. Japan Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Autologous Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Autologous Cell Therapy Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Autologous Cell Therapy Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Autologous Cell Therapy Market Share by Country (2019-2030)
    Figure 52. Brazil Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Autologous Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. BioTime Revenue Growth Rate in Autologous Cell Therapy Business (2019-2024)
    Figure 59. Pharmicell Revenue Growth Rate in Autologous Cell Therapy Business (2019-2024)
    Figure 60. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2019-2024)
    Figure 61. Opexa Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2019-2024)
    Figure 62. Vericel Corporation Revenue Growth Rate in Autologous Cell Therapy Business (2019-2024)
    Figure 63. Regeneus Revenue Growth Rate in Autologous Cell Therapy Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension